Results 101 to 110 of about 117,638 (289)

Ebola virus protein VP40 stimulates IL-12– and IL-18–dependent activation of human natural killer cells

JCI Insight, 2022
Accumulation of activated natural killer (NK) cells in tissues during Ebola virus infection contributes to Ebola virus disease (EVD) pathogenesis. Yet, immunization with Ebola virus-like particles (VLPs) comprising glycoprotein and matrix protein VP40 ...
Hung Le, Paul Spearman, Stephen N. Waggoner, Karnail Singh   +3 more
doaj   +1 more source

Did Neoliberalizing West African Forests Produce a New Niche for Ebola? [PDF]

, 2015
A recent study introduced a vaccine that controls Ebola Makona, the Zaire ebolavirus variant that has infected 28,000 people in West Africa. We propose that even such successful advances are insufficient for many emergent diseases.
Bergmann, L, Gilbert, M, Hogerwerf, L, Kock, R A, Mattioli, R, Pittiglio, C, Wallace, R, Wallace, R G   +7 more
core   +1 more source

Kikwit Ebola Virus Disease Progression in the Rhesus Monkey Animal Model [PDF]

, 2020
Richard S. Bennett, James Logue, David X. Liu, Rebecca Reeder, Krisztina Janosko, Donna L. Perry, Timothy K. Cooper, Russell Byrum, Danny Ragland, Marisa St. Claire, Ricky Adams, Tracey Burdette, Tyler Brady, Kyra Hadley, Mary‐Jo Waters, Rebecca Shim, William E. Dowling, Jing Qin, Ian Crozier, Peter B. Jahrling, Lisa E. Hensley   +20 more
openalex   +1 more source

Effective communication and public engagement strategies to counter misinformation about infectious diseases

Immunology &Cell Biology, EarlyView.
Public trust and cooperation in infectious disease control rest on three pillars: engagement, vaccine communication, and data presentation. Together, these foundations support resilient and inclusive public health responses to misinformation and uncertainty.
Sheena Cruickshank, Martin McKee, Christina Pagel   +2 more
wiley   +1 more source

Ebola Virus Antibodies in Fruit Bats, Bangladesh

Emerging Infectious Diseases, 2013
To determine geographic range for Ebola virus, we tested 276 bats in Bangladesh. Five (3.5%) bats were positive for antibodies against Ebola Zaire and Reston viruses; no virus was detected by PCR.
Kevin J. Olival, Ariful Islam, Meng Yu, Simon J. Anthony, Jonathan H. Epstein, Shahneaz Ali Khan, Salah Uddin Khan, Gary Crameri, Lin-Fa Wang, W. Ian Lipkin, Stephen P. Luby, Peter Daszak   +11 more
doaj   +1 more source

Ebola virus disease: facts and fears [PDF]

, 2015
Ebola virus (EBOV) is an enveloped virus including a negative single strand genome in its virion with cylindrical/tubular morphology. EBOV is the causative agent of Ebola virus disease (EVD), which is also involved in the outbreak observed in Central ...
Karimi, A.
core  

The Social and Political Dimensions of the Ebola Response: Global Inequality, Climate Change, and Infectious Disease [PDF]

, 2016
The 2014 Ebola crisis has highlighted public-health vulnerabilities in Liberia, Sierra Leone, and Guinea – countries ravaged by extreme poverty, deforestation and mining-related disruption of livelihoods and ecosystems, and bloody civil wars in the ...
A Kay, A Mabin, A Petherick, AM Saéz, AR Poteete, AT Price-Smith, BA Israel, C Bayntun, D Healy, DA Oladele, E Goffman, E Roe, G Bankoff, G Mitman, GB Cockerham, H Frumkin, I Rashid, J Chippaux, J Moran-Ellis, JC Cohen, JC Dumont, JD Mayer, JE Pinzon, K Lee, KC Seto, M Karamouzian, M Nichter, N Brenner, NL Klenk, P Wald, R Bloch, R Bloch, R Keil, R Keil, R Shields, RE Kasperson, S Baize, S Harman, S Lewis, SH Ali, SM Teutsch, T Olaniyan   +41 more
core   +1 more source

Exploring the Impact of COVID‐19 on Acute Care Nurses: An Integrative Review

Journal of Advanced Nursing, EarlyView.
ABSTRACT Aim To analyse, critique, and synthesise available research to create a unique framework of the impacts of COVID‐19 on acute care nurses. Methods Whittemore and Knafl's framework was used to organise this review. The Mixed Methods Appraisal Tool was used for quality analysis.
Janelle Schentag, Kelly Penz, Helen Vandenberg   +2 more
wiley   +1 more source

Uveitis and Systemic Inflammatory Markers in Convalescent Phase of Ebola Virus Disease

Emerging Infectious Diseases, 2016
We report a case of probable Zaire Ebola virus–related ophthalmologic complications in a physician from the United States who contracted Ebola virus disease in Liberia.
John R. Chancellor, Sriranjani P. Padmanabhan, Thomas C. Greenough, Richard Sacra, Richard T. Ellison, Lawrence C. Madoff, Rebecca J. Droms, David M. Hinkle, George K. Asdourian, Robert W. Finberg, Ute Stroher, Timothy M. Uyeki, Olga M. Cerón   +12 more
doaj   +1 more source

Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study. [PDF]

, 2015
BACKGROUND: Clinical management of Ebola virus disease remains challenging. Routine laboratory analytics are often unavailable in the outbreak setting, and few data exist for the associated haematological and biochemical abnormalities. We aimed to assess
Brooks, Tim, Conteh, Sulaiman, Cummings, Rachael, Fletcher, Tom, Gupta-Wright, Ankur, Heisenberg-Mansaray, Saidu, Houlihan, Catherine, Hunt, Luke, Knott, Victoria, Sheriff, Alpha, Simms, Victoria, Smith, Tom, Tamba, Emmanuel, Tamba, Fayia, Tamba, Kongoneh, Tobin, Shelagh   +15 more
core   +1 more source